Editorial: Multiple Myeloma Immunotherapies

E-ISSN： 1873-5576|17|9|768-768

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.17, Iss.9, 2017-10, pp. : 768-768

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple myeloma

By Samson Diana Singer Charles

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 365-370

Royal College Of Physicians

Access to resources Recommend Favorite

Bortezomib in multiple myeloma

By Terpos Evangelos Roussou Maria Dimopoulos Meletios-Athanassios

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 5, 2008-05 ,pp. : 639-654

Informa Healthcare

Access to resources Recommend Favorite

Breakthroughs in the Management of Multiple Myeloma

By Heffner Jr L.T. Lonial S.

Drugs, Vol. 63, Iss. 16, 2003-01 ,pp. : 1621-1636

Adis International

Access to resources Recommend Favorite

Thalidomide in multiple myeloma

By García-Sanz Ramón

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 195-213

Informa Healthcare

Access to resources Recommend Favorite

Novel therapy in multiple myeloma

By Avilés Agustin Neri Natividad Nambo M. Cleto Sergio Castañeda Claudia González Martha Talavera Alejandra Huerta-Guzmán Judith

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 411-415

Springer Publishing Company

Access to resources Recommend Favorite